查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530936

前列腺健康市场 - 全球产业分析、规模、份额、成长、趋势和预测，2024-2034 年

Prostate Health Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 213 Pages | 商品交期: 2-10个工作天内

价格

摄护腺健康市场 - 报告范围

TMR 关于全球前列腺健康市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。 ，考虑2024年为基准年，2034年为预测年。报告中也提供了2024年至2034年全球摄护腺健康市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解前列腺健康市场。

市场概况
2023年市场价值 3190万美元
2034 年市场价值 838 亿美元
复合年增长率 9.2%

该报告深入研究了全球前列腺健康市场的竞争格局。全球前列腺健康市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球前列腺健康市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034年全球市场分析与预测

第 5 章：关键见解

  • 按地区/全球分類的监管情景
  • 关键产业活动（产品发布、合作与伙伴关係、收购、核准等）
  • 管道分析
  • 主要国家的报销情况
  • 摄护腺疾病（摄护腺炎、良性摄护腺增生、摄护腺癌等）的疾病诊断
  • 品牌分析
  • 定价分析
  • Covid-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依疾病类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依疾病类型，2020-2034
    • 摄护腺炎
    • 良性摄护腺增生（BPH）
    • 摄护腺癌
      • 腺癌
      • 移行细胞癌
      • 鳞状细胞癌
      • 小细胞前列腺癌
  • 市场吸引力分析：按疾病类型

第 7 章：全球市场分析与预测：按处理方式

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依处理方式，2020-2034
    • 化疗
    • 荷尔蒙疗法
    • 免疫疗法
  • 市场吸引力分析：按处理方式

第 8 章：全球市场分析与预测：按管理途径

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依给药途径，2020-2034年
    • 口服
    • 注射用
  • 市场吸引力分析：按给药途径

第 9 章：全球市场分析与预测：按配销通路

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2020-2034
    • 医院药房
    • 零售药局
    • 网路药局
  • 市场吸引力分析：按配销通路

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2034
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按地区分類的市场吸引力

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司市占率分析 (2023)
  • 公司简介
    • Abbott Laboratories
    • Amgen Inc.
    • Astellas Pharma Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Bristol-Myers Squibb (BMS)
    • Eli Lilly and Company
    • Ferring Pharmaceuticals
    • GSK PLC.
    • Johnson & Johnson
    • Merck and Co. Inc.
    • Pfizer Inc.
    • Siemens Healthineers AG
Product Code: TMRGL84727

Prostate Health Market - Scope of Report

TMR's report on the global prostate health market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global prostate health market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global prostate health market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the prostate health market.

Market Snapshot
Market Value in 2023US$ 31.9 Mn
Market Value in 2034US$ 83.8 Bn
CAGR9.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global prostate health market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global prostate health market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global prostate health market.

The report delves into the competitive landscape of the global prostate health market. Key players operating in the global prostate health market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global prostate health market profiled in this report.

Key Questions Answered in Global prostate health Market Report:

  • What is the sales/revenue generated by prostate health across all regions during the forecast period?
  • What are the opportunities in the global prostate health market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Prostate Health Market - Research Objectives and Research Approach

The comprehensive report on the global prostate health market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global prostate health market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global prostate health market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Prostate Health Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Prostate Health Market Analysis and Forecast, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Regulatory Scenario by region/globally
  • 5.2. Key Industry Events (Product Launches, Collaborations and Partnerships, Acquisitions, Approvals etc.)
  • 5.3. Pipeline Analysis
  • 5.4. Reimbursement Scenario by Key Countries
  • 5.5. Disease Diagnosis of Prostate Diseases (Prostatitis, Benign Prostate Hyperplasia, Prostate Cancer, etc.)
  • 5.6. Brand Analysis
  • 5.7. Pricing Analysis
  • 5.8. Covid-19 Pandemic Impact on Industry

6. Global Prostate Health Market Analysis and Forecast, by Disease Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Disease Type, 2020-2034
    • 6.3.1. Prostatitis
    • 6.3.2. Benign Prostatic Hyperplasia (BPH)
    • 6.3.3. Prostate Cancer
      • 6.3.3.1. Adenocarcinoma
      • 6.3.3.2. Transitional Cell Carcinoma
      • 6.3.3.3. Squamous Cell Carcinoma
      • 6.3.3.4. Small Cell Prostate Cancer
  • 6.4. Market Attractiveness Analysis, by Disease Type

7. Global Prostate Health Market Analysis and Forecast, by Treatment

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Treatment, 2020-2034
    • 7.3.1. Chemotherapy
    • 7.3.2. Hormone Therapy
    • 7.3.3. Immunotherapy
  • 7.4. Market Attractiveness Analysis, by Treatment

8. Global Prostate Health Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2020-2034
    • 8.3.1. Oral
    • 8.3.2. Parenteral
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Prostate Health Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2020-2034
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Prostate Health Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Prostate Health Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Disease Type, 2020-2034
    • 11.2.1. Prostatitis
    • 11.2.2. Benign Prostatic Hyperplasia (BPH)
    • 11.2.3. Prostate Cancer
      • 11.2.3.1. Adenocarcinoma
      • 11.2.3.2. Transitional Cell Carcinoma
      • 11.2.3.3. Squamous Cell Carcinoma
      • 11.2.3.4. Small Cell Prostate Cancer
  • 11.3. Market Value Forecast, by Treatment, 2020-2034
    • 11.3.1. Chemotherapy
    • 11.3.2. Hormone Therapy
    • 11.3.3. Immunotherapy
  • 11.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 11.4.1. Oral
    • 11.4.2. Parenteral
  • 11.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast, by Country
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Disease Type
    • 11.7.2. By Treatment
    • 11.7.3. By Route of Administration
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Prostate Health Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Disease Type, 2020-2034
    • 12.2.1. Prostatitis
    • 12.2.2. Benign Prostatic Hyperplasia (BPH)
    • 12.2.3. Prostate Cancer
      • 12.2.3.1. Adenocarcinoma
      • 12.2.3.2. Transitional Cell Carcinoma
      • 12.2.3.3. Squamous Cell Carcinoma
      • 12.2.3.4. Small Cell Prostate Cancer
  • 12.3. Market Value Forecast, by Treatment, 2020-2034
    • 12.3.1. Chemotherapy
    • 12.3.2. Hormone Therapy
    • 12.3.3. Immunotherapy
  • 12.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 12.4.1. Oral
    • 12.4.2. Parenteral
  • 12.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. UK
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Disease Type
    • 12.7.2. By Treatment
    • 12.7.3. By Route of Administration
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Prostate Health Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Disease Type, 2020-2034
    • 13.2.1. Prostatitis
    • 13.2.2. Benign prostatic hyperplasia (BPH)
    • 13.2.3. Prostate Cancer
      • 13.2.3.1. Adenocarcinoma
      • 13.2.3.2. Transitional Cell Carcinoma
      • 13.2.3.3. Squamous Cell Carcinoma
      • 13.2.3.4. Small Cell Prostate Cancer
  • 13.3. Market Value Forecast, by Treatment, 2020-2034
    • 13.3.1. Chemotherapy
    • 13.3.2. Hormone Therapy
    • 13.3.3. Immunotherapy
  • 13.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 13.4.1. Oral
    • 13.4.2. Parenteral
  • 13.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Disease Type
    • 13.7.2. By Treatment
    • 13.7.3. By Route of Administration
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country/Sub-region

14. Latin America Prostate Health Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Disease Type, 2020-2034
    • 14.2.1. Prostatitis
    • 14.2.2. Benign prostatic hyperplasia (BPH)
    • 14.2.3. Prostate Cancer
      • 14.2.3.1. Adenocarcinoma
      • 14.2.3.2. Transitional Cell Carcinoma
      • 14.2.3.3. Squamous Cell Carcinoma
      • 14.2.3.4. Small Cell Prostate Cancer
  • 14.3. Market Value Forecast, by Treatment, 2020-2034
    • 14.3.1. Chemotherapy
    • 14.3.2. Hormone Therapy
    • 14.3.3. Immunotherapy
  • 14.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 14.4.1. Oral
    • 14.4.2. Parenteral
  • 14.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Disease Type
    • 14.7.2. By Treatment
    • 14.7.3. By Route of Administration
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Prostate Health Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Disease Type, 2020-2034
    • 15.2.1. Prostatitis
    • 15.2.2. Benign prostatic hyperplasia (BPH)
    • 15.2.3. Prostate Cancer
      • 15.2.3.1. Adenocarcinoma
      • 15.2.3.2. Transitional Cell Carcinoma
      • 15.2.3.3. Squamous Cell Carcinoma
      • 15.2.3.4. Small Cell Prostate Cancer
  • 15.3. Market Value Forecast, by Treatment, 2020-2034
    • 15.3.1. Chemotherapy
    • 15.3.2. Hormone Therapy
    • 15.3.3. Immunotherapy
  • 15.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 15.4.1. Oral
    • 15.4.2. Parenteral
  • 15.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies
  • 15.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Disease Type
    • 15.7.2. By Treatment
    • 15.7.3. By Route of Administration
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Abbott Laboratories
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Amgen Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Astellas Pharma Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. AstraZeneca PLC
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Bayer AG
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Bristol-Myers Squibb (BMS)
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Eli Lilly and Company
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Ferring Pharmaceuticals
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. GSK PLC.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Johnson & Johnson
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Merck and Co. Inc.
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. Pfizer Inc.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. Siemens Healthineers AG
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview

List of Tables

  • Table 01: Global Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 02: Global Prostate Health Market Value (US$ Mn) Forecast, by Prostate cancer, 2020-2034
  • Table 03: Global Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 04: Global Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 05: Global Prostate Health Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Prostate Health Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 08: North America Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 09: North America Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 10: North America Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 11: Europe Prostate Health Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 13: Europe Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 14: Europe Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 15: Europe Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 16: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 18: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 19: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 20: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 21: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 23: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 24: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 25: Latin America Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 26: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 28: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Prostate Cancer, 2020-2034
  • Table 29: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Treatment, 2020-2034
  • Table 30: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Global Prostate Health Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global Prostate Health Market Value Share, by Disease Type, 2023
  • Figure 03: Global Prostate Health Market Value Share, by Treatment, 2023
  • Figure 04: Global Prostate Health Market Value Share, by Route of Administration, 2023
  • Figure 05: Global Prostate Health Market Value Share, by Distribution Channel, 2023
  • Figure 06: Global Prostate Health Market Value Share, by Region, 2023
  • Figure 07: Global Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 08: Global Prostate Health Market Share Analysis, by Disease Type, 2023
  • Figure 09: Global Prostate Health Market Share Analysis, by Disease Type, 2034
  • Figure 10: Global Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 11: Global Prostate Health Market Value (US$ Mn), by Prostatitis, 2020-2034
  • Figure 12: Global Prostate Health Market Value Share Analysis, by Prostatitis, 2023 and 2034
  • Figure 13: Global Prostate Health Market Value (US$ Mn), by Benign prostatic hyperplasia (BPH), 2020-2034
  • Figure 14: Global Prostate Health Market Value Share Analysis, by Benign prostatic hyperplasia (BPH), 2023 and 2034
  • Figure 15: Global Prostate Health Market Value (US$ Mn), by Prostate cancer, 2020-2034
  • Figure 16: Global Prostate Health Market Value Share Analysis, by Prostate cancer, 2023 and 2034
  • Figure 17: Global Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 18: Global Prostate Health Market Share Analysis, by Treatment, 2023
  • Figure 19: Global Prostate Health Market Share Analysis, by Treatment, 2034
  • Figure 20: Global Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 21: Global Prostate Health Market Value (US$ Mn), by Chemotherapy, 2020-2034
  • Figure 22: Global Prostate Health Market Value Share Analysis, by Chemotherapy, 2023 and 2034
  • Figure 23: Global Prostate Health Market Value (US$ Mn), by Hormone Therapy, 2020-2034
  • Figure 24: Global Prostate Health Market Value Share Analysis, by Hormone Therapy, 2023 and 2034
  • Figure 25: Global Prostate Health Market Value (US$ Mn), by Immunotherapy, 2020-2034
  • Figure 26: Global Prostate Health Market Value Share Analysis, by Immunotherapy, 2023 and 2034
  • Figure 27: Global Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 28: Global Prostate Health Market Share Analysis, by Distribution Channel, 2023
  • Figure 29: Global Prostate Health Market Share Analysis, by Distribution Channel, 2034
  • Figure 30: Global Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 31: Global Prostate Health Market Value (US$ Mn), by Hospital Pharmacies, 2020-2034
  • Figure 32: Global Prostate Health Market Value Share Analysis, by Hospital Pharmacies, 2023 and 2034
  • Figure 33: Global Prostate Health Market Value (US$ Mn), by Retail Pharmacies, 2020-2034
  • Figure 34: Global Prostate Health Market Value Share Analysis, by Retail Pharmacies, 2023 and 2034
  • Figure 35: Global Prostate Health Market Value (US$ Mn), by Online Pharmacies, 2020-2034
  • Figure 36: Global Prostate Health Market Value Share Analysis, by Online Pharmacies, 2023 and 2034
  • Figure 37: Global Prostate Health Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 38: Global Prostate Health Market Share Analysis, by Region, 2023
  • Figure 39: Global Prostate Health Market Share Analysis, by Region, 2034
  • Figure 40: Global Prostate Health Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 41: North America Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 42: North America Prostate Health Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 43: North America Prostate Health Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 44: North America Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 45: North America Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 46: North America Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 47: North America Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 48: North America Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 49: North America Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 50: Europe Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 51: Europe Prostate Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 52: Europe Prostate Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 53: Europe Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 54: Europe Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 55: Europe Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 56: Europe Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 57: Europe Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 58: Europe Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 59: Asia Pacific Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 60: Asia Pacific Prostate Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 61: Asia Pacific Prostate Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 62: Asia Pacific Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 63: Asia Pacific Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 64: Asia Pacific Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 65: Asia Pacific Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 66: Asia Pacific Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 67: Asia Pacific Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 68: Latin America Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 69: Latin America Prostate Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 70: Latin America Prostate Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 71: Latin America Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 72: Latin America Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 73: Latin America Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 74: Latin America Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 75: Latin America Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 76: Latin America Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 77: Middle East & Africa Prostate Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 78: Middle East & Africa Prostate Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 79: Middle East & Africa Prostate Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 80: Middle East & Africa Prostate Health Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 81: Middle East & Africa Prostate Health Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 82: Middle East & Africa Prostate Health Market Value (US$ Mn) Share Analysis, by Treatment, 2023 and 2034
  • Figure 83: Middle East & Africa Prostate Health Market Attractiveness Analysis, by Treatment, 2024-2034
  • Figure 84: Middle East & Africa Prostate Health Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 85: Middle East & Africa Prostate Health Market Attractiveness Analysis, by Distribution Channel, 2024-2034